0000950170-24-004305.txt : 20240112 0000950170-24-004305.hdr.sgml : 20240112 20240112172729 ACCESSION NUMBER: 0000950170-24-004305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240110 FILED AS OF DATE: 20240112 DATE AS OF CHANGE: 20240112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reilly Thomas Charles CENTRAL INDEX KEY: 0001827590 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 24532976 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 ownership.xml 4 X0508 4 2024-01-10 0000897448 AMARIN CORP PLC\UK AMRN 0001827590 Reilly Thomas Charles C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807 false true false false EVP and CFO false Ordinary Shares 2024-01-10 4 M false 51500 A 76875 D Ordinary Shares 2024-01-10 4 F false 28325 0.97 D 48550 D Restricted Stock Unit 0.00 2024-01-10 4 A false 51500 0.00 A Ordinary Shares 51500 0 D Restricted Stock Unit 2024-01-10 4 M false 51500 0.00 D Ordinary Shares 51500 0 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 10, 2024, the first of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. Not applicable Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. /s/ Tom Reilly 2024-01-12